Efficacy of the Kampo medicine in prevention of classical migraine

Abstract

The efficacy of Kampo treatment in patients with migraine was studied. 1,094 patients with miraine with or without aura under the international classification of headache disorders 3rd edtition (berta version) were treated by Kampo. The Kampo used were: tokishakuyakusan 96 (23.4%), gosyuyuto 72 patients (17.6%), goreisan 90 (21.9%), kakkonto 106 (25.9%), tokishigyakukagoshuyushokyoto 29 (7.1%), kamisyoyosan 29 (7.1%), hangebyakujyutsutemmato 10 (2.4%), chotosan 10 (2.4%). Patients who treated by Kampo 3 months, reduction of frequency and severity were estimated in 208 patients (50.7%). In conclusion, Kampo treatment was suggested to be an effective option for the treatment of patients with migraine.